Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Combination therapy comprising a MAT2A inhibitor and a type II PRMT inhibitor

Combination therapy comprising a MAT2A inhibitor and a type II PRMT inhibitor

US Patent 12115163 · Granted Oct 15, 2024

Estimated economic value: $27,530,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Aminopyridine derivatives and their use as selective ALK-2 inhibitors2025
Thiadiazolyl derivatives as DNA polymerase theta inhibitors and uses thereof2025
Thiadiazolyl derivatives as DNA polymerase theta inhibitors and uses thereof2025
Piperazine substituted indazole compounds as inhibitors of PARG2025
AhR modulators2025
Dihydrothieno[3,2-b]pyridine compounds2023
Amido compounds as AhR modulators2023
AhR modulators2022
Aminopyridine derivatives and their use as selective ALK-2 inhibitors2021
AhR modulators2020
Biaryl amide compounds as kinase inhibitors2020
Aminopyridine derivatives and their use as selective ALK-2 inhibitors2020